Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving Low Dose FVIII Prophylaxis

NCT06816953 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT06816953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06816953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cartilage Biomarkers and HEAD-US Score in Severe Hemophilia A Patients Receiving Low Dose FVIII Prophylaxis
Lead sponsor
Chulalongkorn University
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
April 1, 2024
Completion date
February 28, 2025
Enrollment
19 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a